Author:
Mirsepasi-Lauridsen Hengameh C.,Halkjaer Sofie Ingdam,Mortensen Esben Munk,Lydolph Magnus C.,Nordgaard-Lassen Inge,Krogfelt Karen Angeliki,Petersen Andreas Munk
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Head, K. a, Jurenka, J. S. & Ascp, M. T. Inflammatory Bowel Disease Part I : Ulcerative Colitis–Pathophysiology and Conventional and Alternative Treatment Options. Altern Med Rev 8, 247–283 (2003).
2. Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 1–9 10.1136/gutjnl-2013-304833 (2013).
3. Petersen, A. M. et al. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol. 9, 171–179 (2009).
4. Kotlowski, R., Bernstein, C. N., Sepehri, S. & Krause, D. O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56, 669–675 (2007).
5. Vejborg, R. M., Hancock, V., Petersen, A. M., Krogfelt, K. a. & Klemm, P. Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genomics 12, 316 (2011).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献